𝛼SK or SearchChong Kun Dang (185750 KS/Buy)Limited Earnings Improvement, but Pipeline Development on Track
Our target price for Chong Kun Dang is based on the sum of operating value (W1.1tr; revised down from W1.7tr) and pipeline value (W210.7bn).
What is covered in the Full Insight:
- Target Price and Valuation
- Pipeline Development
- 2026 Financial Forecast
- Market Comparison
- Revised Earnings Estimates
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 17-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Chong Kun Dang Pharmaceutical - Chairman Gifts All His 9.6% Stake to His Children29 Aug 2026
- Chong Kun Dang (185750 KS/Buy)Limited Earnings Improvement, but Pipeline Development on Track28 Aug 2026
x